Précédent|Prochain

Le sérum de nettoyage et d'hydratation régule la voie de signalisation BCAAs/mTOR pour améliorer la résistance à l'insuline des cellules HepG2

  • role： First author第一作者
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

  • Email：bxw@xmu.edu.cn
  • Introduction：卜祥伟，博士，主治医师，从事中医药防治内分泌代谢病的临床及基础研究，E-mail：bxw@xmu.edu.cn
BU Xiangwei1,  
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

HAO Xiaohui1,  
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

ZHANG Runyun1,  
  • Affiliation：

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine（TCM），Tianjin 300381，China

ZHANG Meizhen2,  
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

WANG Ze1,  
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

WANG Haoshuo1,  
  • Affiliation：

    Shunyi Hospital，Beijing TCM Hospital，Beijing 101300，China

WANG Jie3,  
  • role： Corresponding author通信作者
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

  • Email：niqing669@163.com
  • Introduction：倪青，博士，主任医师，博士生导师，从事内分泌代谢病的中医药诊疗研究，E-mail：niqing669@163.com； *
NI Qing1*,  
  • role： Corresponding author通信作者
  • Affiliation：

    Guang'anmen Hospital，China Academy of Chinese Medicine Sciences，Beijing 100053，China

  • Email：linlan2042@gamyy.cn
  • Introduction：林兰，主任医师，博士生导师，从事内分泌代谢病的中医药防治研究，E-mail：linlan2042@gamyy.cn
LIN Lan1*

résumé

L'objectif est d'étudier l'effet du sérum de nettoyage et d'hydratation sur l'amélioration de la résistance à l'insuline des cellules HepG2 et son mécanisme d'action potentiel.

mots-clés

sérum de nettoyage et d'hydratation; diabète de type 2; résistance à l'insuline; reprogrammation métabolique; acides aminés à chaîne ramifiée

References

  1. 1.
    DE BANDT J P，COUMOUL X，BAROUKI R.Branched-chain amino acids and insulin resistance，from protein supply to diet-induced obesity［J］.Nutrients，2022，15（1）：68.
  2. 2.
    WHITE P J，MCGARRAH R W，HERMAN M A，et al.Insulin action，type 2 diabetes，and branched-chain amino acids：A two-way street［J］.Mol Metab，2021，52：101261.
  3. 3.
    ZHANG X H，ZHANG S Y，LI L.Amino acid metabolic reprogramming in tumorigenesis and development［J］.Chin J Biochem Mol Biol，2023，39（2）：174-188.
  4. 4.
    GAR C，ROTTENKOLBER M，PREHN C，et al.Serum and plasma amino acids as markers of prediabetes，insulin resistance，and incident diabetes［J］.Crit Rev Clin Lab Sci，2018，55（1）：21-32.
  5. 5.
    LIN L，NI Q，PANG J L，et al.Therapeutic efficacy evaluation by a randomized controlled clinical research on traditional Chinese medical formulas，with herb modification according to syndrome differentiation，in the treatment of 200 type 2 diabetic patients［J］.J Med Res，2013，42（2）：102-107.
  6. 6.
    BU X W，HAO X H，ZHANG M Z，et al.Mechanism of Qingrun formula in improving hepatic insulin resistance of rats with type 2 diabetes mellitus based on high-throughput sequencing［J］.World Chin Med，2024，19（11）：1599-1607，1613
  7. 7.
    QIU ZL，WANG Q H，SUN F H，et al.Effect of Qingrun formula on SIRT/NF-κB signal pathway in liver of diabetic rats［J］.China Med Herald，2018，15（28）：4-7，12
  8. 8.
    QIU Z L，WANG Q H，SUN F H，et al.Effect of Qingrunfang on signal pathway of PI3K/Akt/mTOR in liver of diabetic rats［J］.J Med Res，2018，47（12）：37-40，45.
  9. 9.
    WANG Z.Investigate on the mechanism of Qingrun formula to improve hepatic insulin resistance in type 2 diabetes mellitus based on miR-34a regulating SIRT1/NF-κB signaling pathway［D］.Beijing：China Academy of Chinese Medical Sciences，2020.
  10. 10.
    YUDHANI R D，SARI Y，NUGRAHANINGSIH D，et al.In vitro insulin resistance model：A recent update［J］.J Obes，2023，2023：1964732.
  11. 11.
    LIN X L，LI Y，GUO M Q，et al.Berberine promotes expression of AQP4 in astrocytes by regulating production of miR-383-5p in HepG2 cell-derived exosomes under insulin resistance［J］.China J Chin Mater Med，2025，50（3）：768-775.
  12. 12.
    LI X L，HE S M，ZHU Y，et al.Establishment and identify of HepG2 cells model of insulin resistance［J］.Chin J Exp Tradit Med Form，2013，19（5）：203-207.
  13. 13.
    YANG S，XU J P.Effect of oleuropein on insulin signal transduction in insulin-resistant HepG2 hepatocytes［J］.Chin J Exp Tradit Med Form，2018，24（20）：164-168.
  14. 14.
    LI D F，FAN J L，DU L，et al.Glabridin ameliorates insulin resistance by regulating ERK/IRS-1 and PI3K/Akt signaling pathways in HepG2 cells［J］.Chin Tradit Herb Drugs，2022，53（24）：7751-7762.
  15. 15.
    XUE L，SHI Y.Effects of Yitangkang on glucose consumption and IRS-2/PI3K/Akt signaling pathway in IR-HepG2 cells［J］.Lishizhen Med Mater Med Res，2022，33（10）：2374-2377.
  16. 16.
    WEI N Q，HAO E W，XIAN H M，et al.Molecular mechanism of Gynura divaricata on insulin resistance in HepG2 cells［J］.Chin J Exp Tradit Med Form，2018，24（2）：110-115.
  17. 17.
    PANG X J，LU L L，LI D W，et al.Effect of total flavonoids from Bidens pilosa on insulin resistance in HepG2 cells［J］.China Pharm，2022，33（8）：968-974.
  18. 18.
    LIN L.Modern traditional Chinese medicine diabetes science［M］.Beijing：People's Medical Publishing House，2008.
  19. 19.
    GIESBERTZ P，DANIEL H.Branched-chain amino acids as biomarkers in diabetes［J］.Curr Opin Clin Nutr Metab Care，2016，19（1）：48-54.
  20. 20.
    CUI L，LI Z，LIU X，et al.Association between serum branched chain amino acids，mammalian target of rapamycin levels and the risk of gestational diabetes mellitus：A 1∶1 matched case control study［J］.BMC Pregnancy Childbirth，2024，24（1）：633.
  21. 21.
    ZHAO X，GANG X，LIU Y，et al.Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity： A systematic review［J］.J Diabetes Res，2016，2016：8160545.
  22. 22.
    JANG C，OH S F，WADA S，et al.A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance［J］.Nat Med，2016，22（4）：421-426.
  23. 23.
    HOLEČEK M.Branched-chain amino acids in health and disease：Metabolism，alterations in blood plasma，and as supplements［J］.Nutr Metab（Lond），2018，15：33.
  24. 24.
    MENNI C，FAUMAN E，ERTE I，et al.Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach［J］.Diabetes，2013，62（12）：4270-4276.
  25. 25.
    MANN G，ADEGOKE O.Effects of ketoisocaproic acid and inflammation on glucose transport in muscle cells［J］.Physiol Rep，2021，9（1）：e14673.
  26. 26.
    BISWAS D，DAO K T，MERCER A，et al.Branched-chain ketoacid overload inhibits insulin action in the muscle［J］.J Biol Chem，2020，295（46）：15597-15621.
  27. 27.
    WäLCHLI M，BERNEISER K，MANGIA F，et al.Regulation of human mTOR complexes by DEPTOR［J］.Elife，2021，10：e70871.
  28. 28.
    UM S H，D'ALESSIO D，THOMAS G.Nutrient overload，insulin resistance，and ribosomal protein S6 kinase 1，S6K1［J］.Cell Metab，2006，3（6）：393-402.
  29. 29.
    DÜVEL K，YECIES J L，MENON S，et al.Activation of a metabolic gene regulatory network downstream of mTOR complex 1［J］.Mol Cell，2010，39（2）：171-183.
  30. 30.
    FERNANDES S A，ANGELIDAKI D D，NÜCHEL J，et al.Spatial and functional separation of mTORC1 signalling in response to different amino acid sources［J］.Nat Cell Biol，2024，26（11）：1918-1933.
  31. 31.
    QUAN S Y，NAN X M，JIANG L S，et al.Research progress on animal amino acid transport and sensing systems［J］.Chin J Anim Nutr，2018，30（10）：3810-3817.
  32. 32.
    YE Y Y，HUANG Y J，YIN Y L，et al.Mechanism of mTORC1 and GCN2 in regulating development，differentiation，and function of immune cells［J］.Sci China Life Sci，2023，53（7）：1012-1020.
  33. 33.
    BISWAS D，DUFFLEY L，PULINILKUNNIL T.Role of branched-chain amino acid-catabolizing enzymes in intertissue signaling，metabolic remodeling，and energy homeostasis［J］.FASEB J，2019，33（8）：8711-8731.
  34. 34.
    SHULMAN G I.Cellular mechanisms of insulin resistance［J］.J Clin Invest，2000，106（2）：171-176
  35. 35.
    WHITE P J，NEWGARD C B.Branched-chain amino acids in disease［J］.Science，2019，363（6427）：582-583.
  36. 36.
    WHITE P J，MCGARRAH R W，GRIMSRUD P A，et al.The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase［J］.Cell Metab，2018，27（6）：1281-1293，e7.
  37. 37.
    ZHOU M，SHAO J，WU C Y，et al.Targeting BCAA catabolism to treat obesity-associated insulin resistance［J］.Diabetes，2019，68（9）：1730-1746.
  38. 38.
    ZHOU F，SHENG C，MA X，et al.BCKDH kinase promotes hepatic gluconeogenesis independent of BCKDHA［J］.Cell Death Dis，2024，15（10）：736.

Lire l'article complet

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website